Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis von Schoenleber, S J, Kurtz, D M, Talwalkar, J A, Roberts, L R, Gores, G J

Volltext

Rubrerythrin and rubredoxin oxidoreductase in Desulfovibrio vulgaris: a novel oxidative stress protection system von Lumppio, H L, Shenvi, N V, Summers, A O, Voordouw, G, Kurtz, Jr, D M

Volltext

A Role for Rubredoxin in Oxidative Stress Protection in Desulfovibrio vulgaris: Catalytic Electron Transfer to Rubrerythrin and Two-Iron Superoxide Reductase von Coulter, Eric D., Kurtz, Donald M.

Volltext

Five-gene cluster in Clostridium thermoaceticum consisting of two divergent operons encoding rubredoxin oxidoreductase- rubredoxin and rubrerythrin-type A flavoprotein- high-molecu... von Das, A, Coulter, E D, Kurtz, Jr, D M, Ljungdahl, L G

Volltext

NADH Peroxidase Activity of Rubrerythrin von Coulter, E.D., Shenvi, N.V., Kurtz, D.M.

Volltext

Combined autologous CD30.CAR‐T cells and nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma after failure of frontline therapy (ACTION study) von Ahmed, S., Mei, M., Kurtz, D. M., Beitinjaneh, A., Grover, N. S., Ramos, C. A., Chabon, J. J., Schultz, A., Ding, C., Myo, A., Alizadeh, A. A., Horak, I. D., Heslop, H. E.

Volltext

Genomic abnormalities involving class I HLA are common in advanced cutaneous T‐cell lymphoma von Kwang, A. C, Duran, G. E., Li, S., Torres, A. N. Bastidas, Herrera, M., Wang, E. B., Kurtz, D. M., Kim, Y. H., Khodadoust, M. S.

Volltext

Distinct molecular determinants of treatment‐failure in elderly Hodgkin lymphoma identified by cell‐free DNA profiling: A LYSA Study von Rossi, C., Boegeholz, J. L., Alig, S. K., Garofolo, A., Esfahani, M. Shahrokh, Schroers‐Martin, J., Olsen, M., Kang, X., Kurtz, D. M., Sugio, T., Hamilton, M. P., André, M., Casasnovas, O., Diehn, M., Ghesquières, H., Alizadeh, A. A.

Volltext

A Hemerythrin-like Domain in a Bacterial Chemotaxis Protein von Xiong, Junjie, Kurtz, Donald M, Ai, Jingyuan, Sanders-Loehr, Joann

Volltext

MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS von Roschewski, M., Kurtz, D. M., Westin, J., Lynch, R. C., Alig, S. K., Macaulay, C., Kuffer, C., Hogan, G. J., Schultz, A., Close, S., Chabon, J. J., Rossi, D., Opat, S., Hicks, R., Hertzberg, M. S., Diehn, M., Wilson, W., Alizadeh, A. A.

Volltext

COMPARATIVE ACCURACY OF ALTERNATIVE EARLY MEASURES OF RESIDUAL DISEASE AFTER CAR19 THERAPY OF RELAPSED/REFRACTORY LBCL von Sworder, B. J., Alig, S. K., Shukla, N., Garofalo, A., Macaulay, C. W., Esfahani, M. Shahrokh, Olsen, M. N., Hamilton, J., Hosoya, H., Hamilton, M. P., Spiegel, J. Y., Baird, J. H., Carleton, M., Younes, S. F., Schroers‐Martin, J. G., Liu, C. L., Natkunam, Y., Majzner, R. G., Mackall, C. L., Miklos, D. B., Diehn, M., Frank, M. J., Kurtz, D. M., Alizadeh, A. A.

Volltext

DISTINCT HODGKIN LYMPHOMA SUBTYPES IDENTIFIED BY NONINVASIVE GENOMIC PROFILING von Alig, S. K., Esfahani, M. Shahrokh, Garofalo, A., Li, M. Y., Rossi, C., Adams, R., Binkley, M. S., Jin, M. C., Olsen, M., Telenius, A., Mutter, J., Sworder, B. J., Schroers‐Martin, J., King, D. A., Schultz, A., Bögeholz, J., Su, S., Kathuria, K. R., Kang, X., Liu, C. L., Spina, V., Tousseyn, T., Buedts, L., Flerlage, T., Flerlage, J. E., Castellino, S. M., Advani, R., Rossi, D., Lynch, R., Ghesquières, H., Casasnovas, O., Kurtz, D. M., Marks, L. J., Link, M. P., André, M., Vandenberghe, P., Steidl, C., Diehn, M., Alizadeh, A. A.

Volltext

Characterization and Evolution of Anthranilate 1,2-Dioxygenase from Acinetobacter sp. Strain ADP1 von Eby, D M, Beharry, Z M, Coulter, E D, Kurtz, Jr, D M, Neidle, E L

Volltext

A CONTINUOUS INDIVIDUALIZED RISK INDEX FOR REFINED OUTCOME PREDICTION AFTER TARGETED THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CIRI‐CLL) von Al‐Sawaf, O., Esfahani, M. S., Zhang, C., Tausch, E., Schilhabel, A., Eichhorst, B., Stilgenbauer, S., Hallek, M., Alizadeh, A. A., Kurtz, D. M., Fischer, K.

Volltext

DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA von Sworder, B, Kurtz, D. M, Alig, S, Frank, M. J, Macauley, C. W, Garofalo, A, Shukla, N, Sahaf, B, Esfahani, M. S, Sheybani, N, Schroers-Martin, J, Liu, C. L, Olsen, M., Spiegel, J. Y, Oak, J, Jin, M. C, Beygi, S, Khodadoust, M. S, Natkunam, Y, Majzner, R, Mackall, C. L, Diehn, M, Miklos, D. M, Alizadeh, A. A

Volltext

MATRIX INDUCTION FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT OR WHOLE‐BRAIN IRRADIATION IN PRIMARY CNS LYMPHOMA. 7‐YEAR RESULTS OF THE IELSG32 RANDOMIZED TRIAL von Mutter, J. A., Alig, S., Lauer, E. M., Esfahani, M. S., Mitschke, J., Kurtz, D. M., Olsen, M., Liu, C. L., Jin, M. C., Bleul, S., Macaulay, C. W., Neidert, N. N., Heiland, D. H., Finke, J., Duyster, J., Wehrle, J., Prinz, M., Illerhaus, G., Reinacher, P. C., Schorb, E., Diehn, M., Alizadeh, A. A., Scherer, F.

Volltext

NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICATION OF PRIMARY CNS LYMPHOMAS BY CTDNA PROFILING von Mutter, J. A., Alig, S., Lauer, E. M., Esfahani, M. S., Mitschke, J., Kurtz, D. M., Olsen, M., Liu, C. L., Jin, M. C., Bleul, S., Macaulay, C. W., Neidert, N. N., Heiland, D. H., Finke, J., Duyster, J., Wehrle, J., Prinz, M., Illerhaus, G., Reinacher, P. C., Schorb, E., Diehn, M., Alizadeh, A. A., Scherer, F.

Volltext

PHASED VARIANTS IMPROVE DLBCL MINIMAL RESIDUAL DISEASE DETECTION AT THE END OF THERAPY von Kurtz, D. M, Chabon, J. J, Soo, J, Co Ting Keh, L, Alig, S, Schultz, A, Jin, M. C, Scherer, F, Craig, A. F. M, Liu, C. L, Dührsen, U, Hüttmann, A, Casasnovas, R.‐O, Westin, J. R, Roschewski, M, Wilson, W. H, Gaidano, G, Rossi, D, Diehn, M, Alizadeh, A. A

Volltext

Dissecting Contributions to the Thermostability of Pyrococcus furiosus Rubredoxin:  β-Sheet Chimeras von Eidsness, Marly K, Richie, Kimberly A, Burden, Amy E, Kurtz, Donald M, Scott, Robert A

Volltext

The structure of Desulfovibrio vulgaris rubrerythrin reveals a unique combination of rubredoxin-like FeS4 and ferritin-like diiron domains von deMaré, Fredrick, Kurtz, Donald M., Nordlund, Pär

Volltext